Enfermedad de Behçet asociada a trombosis venosa
Palabras clave:
úlceras, patergia, uveítis, Behçet, trombosis venosa
Resumen
La enfermedad de Behçet es una enfermedad crónica y multisistémica, caracterizada por uveítis, úlceras orales y úlceras genitales recurrentes. Se reporta un paciente con enfermedad de Behçet asociada a trombosis venosa profunda, que presentó edema en la pierna derecha, úlceras orales y genitales, y pápulopústulas en rodillas. Hubo mejoría clínica con la administración de colchicina y prednisolona.
Citas
1. Behçet H. Some observations on the clinical picture of the socalled triple symptom complex. Dermatologica. 1940;81:73-83.
2. Erdemir AD, Oncel O. Prof. Dr. Hulusi Behcet (a famous Turkish physician) (1889-1948) and Behçet’s disease from the point of view of the history of medicine and some results. J Intl Soc Hist Islamic Med. 2006;5:51-63.
3. Tsai J, Chen GS, Lu YW, Wu CS, Lan CC. Late-onset Behçet’s disease does not correlate with indolent clinical course: Report of seven Taiwanese patients. J Eur Acad Dermatol Venereol. 2008;22:596-600.
4. Pay S, Simsek I, Erdem H, Dinç A. Immunopathogenesis of Behçet’s disease with special emphasize to the possible role of antigen presenting cells. Rheumatol Int. 2007;27:417-24.
5. Alpsoy E, Zouboulis CC, Ehrlich GE. Mucocutaneous lesions of Behcet’s disease. Yonsei Med J. 2007;48:573-85.
6. Yurdakul S, Hamuryudan V, Yazici H. Behçet’s syndrome. Curr Opin Rheumatol. 2004;16:38-42.Evereklioglu C. Current concepts in the etiology and treatment of Behçet’s disease. Surv Ophthalmol. 2005;50:297-350.
7. Calgüneri M, Oztürk MA, Ertenli I, Kiraz S, Apra S, Ozbalkan Z. Effects of interferon a treatment on the clinical course of refractory Behçet’s disease: An open study. Ann Rheum Dis. 2003;62:492-3.
8. Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, et al. EULAR recommendations for the management of Behçet’s disease. Ann Rheum Dis. 2008;67:1656-62.
2. Erdemir AD, Oncel O. Prof. Dr. Hulusi Behcet (a famous Turkish physician) (1889-1948) and Behçet’s disease from the point of view of the history of medicine and some results. J Intl Soc Hist Islamic Med. 2006;5:51-63.
3. Tsai J, Chen GS, Lu YW, Wu CS, Lan CC. Late-onset Behçet’s disease does not correlate with indolent clinical course: Report of seven Taiwanese patients. J Eur Acad Dermatol Venereol. 2008;22:596-600.
4. Pay S, Simsek I, Erdem H, Dinç A. Immunopathogenesis of Behçet’s disease with special emphasize to the possible role of antigen presenting cells. Rheumatol Int. 2007;27:417-24.
5. Alpsoy E, Zouboulis CC, Ehrlich GE. Mucocutaneous lesions of Behcet’s disease. Yonsei Med J. 2007;48:573-85.
6. Yurdakul S, Hamuryudan V, Yazici H. Behçet’s syndrome. Curr Opin Rheumatol. 2004;16:38-42.Evereklioglu C. Current concepts in the etiology and treatment of Behçet’s disease. Surv Ophthalmol. 2005;50:297-350.
7. Calgüneri M, Oztürk MA, Ertenli I, Kiraz S, Apra S, Ozbalkan Z. Effects of interferon a treatment on the clinical course of refractory Behçet’s disease: An open study. Ann Rheum Dis. 2003;62:492-3.
8. Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, et al. EULAR recommendations for the management of Behçet’s disease. Ann Rheum Dis. 2008;67:1656-62.
Cómo citar
1.
Usuga YA, Vargas GA, Velásquez MM, Correa LA. Enfermedad de Behçet asociada a trombosis venosa. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 19 de febrero de 2019 [citado 1 de julio de 2022];20(3):266-9. Disponible en: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/237
Descargas
La descarga de datos todavía no está disponible.
